2019
DOI: 10.1007/s12010-019-03143-6
|View full text |Cite
|
Sign up to set email alerts
|

Aberrant PDK4 Promoter Methylation Preceding Hyperglycemia in a Mouse Model

Abstract: Diabetic prevalence is at speedy increase globally. Previous studies stated that other than genetics, factors such as environment, lifestyle, and paternal-maternal condition play critical roles in diabetes through DNA methylation in specific areas of the genome. The purpose of this study is to investigate the methylation pattern of the PDK4 promoter in streptozotocin-induced diabetic mice until the 12th week of the observation. The methylation pattern in the blood samples was analyzed periodically, while the p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
3
1

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 27 publications
(21 reference statements)
0
3
0
Order By: Relevance
“…Therefore, PDK is an important regulator of PDC, which changes glucose metabolism [ 7 ]. Genetic inactivation of PDK4 is reported to improve hepatic insulin resistance-induced diabetes [ 20 ]. Lower PDK4 expression was found in preadipocytes from obese humans with type 2 diabetes [ 21 ].…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, PDK is an important regulator of PDC, which changes glucose metabolism [ 7 ]. Genetic inactivation of PDK4 is reported to improve hepatic insulin resistance-induced diabetes [ 20 ]. Lower PDK4 expression was found in preadipocytes from obese humans with type 2 diabetes [ 21 ].…”
Section: Discussionmentioning
confidence: 99%
“…Pathways include metabolism [42], transport of small molecules [43] and immune system [44] are linked with progression of FSGS. PDK4 [45], ALB (albumin) [46], EGR1 [47], RYR3 [48], APOH (apolipoprotein H) [49], CYP27B1 [50], ESM1 [51], GATA6 [52], PCK1 [53], TET2 [54], AFP (alpha fetoprotein) [55], CACNA1D [56], ATF3 [57], EGF (epidermal growth factor) [58], LPL (lipoprotein lipase) [59], PPARGC1A [60], PLG (plasminogen) [61], NR4A1 [62], STRA6 [63], MLXIPL (MLX interacting protein like) [64], PLA2G6 [65], RGS2 [66], GPS2 [67], SOX5 [68], GLUL (glutamate-ammonia ligase) [69], RYK (receptor like tyrosine kinase) [70], NFKBIA (NFKB inhibitor alpha) [71], LGR4 [72], SPRY2 [73], TRPC1 [74], KL (klotho) [75], GCLC (glutamate-cysteine ligase catalytic subunit) [76], NOX4 [77], CD69 [78], SLC19A2 [79], S100A12 [80], MT1A [81], SORCS1 [82], FKBP5 [83], AFM (afamin) [84], CA3 [85], MAOA (monoamine oxidase A) [86], ND1 [87], ATP6 [88], CHGA (chromogranin A) [89], ICOS (inducible T cell costimulator) [90], DBH (dopamine beta-hydroxylase) [91], CD5 [92], LTA (lymphotoxin alpha) [93], IFNG (interferon gamma) [94], MPO (myeloperoxidase) [95], CD70 [96], CD300E [97], COLEC12 [98], TLR10 [99], LCN2 [100], SLAMF7 [101], TREM2 [102], ITGAL (integrin subunit alpha L) [103], CD27 [104], JAK3 [105], CCR5 [106], FCN1 [107], IL1RN [108], CX3CR1 [109], PDCD1 [110], TRPM2 [111], PLEK (pleckstrin) [112], CD101 [113],...…”
Section: Discussionmentioning
confidence: 99%
“…High-fat diets also inactivated insulin receptor substrate (IRS-1) in liver and caused inflammation in mice models [15]. Methylation studies on PDK4 also revealed that high-fat-diet-induced methylation on a specific CpG site before the onset of hyperglycemia as one proof of epigenetic regulation plays an important role in metabolic disorder [16].…”
Section: Introductionmentioning
confidence: 99%